BITPRISMIA
Nasdaq-listed biotech firm Windtree Therapeutics plans to raise $520 million for a strategic BNB acquisition, signaling a significant cross-industry investment between biotech and cryptocurrency.
Windtree Therapeutics partners with Kraken to establish a $200 million BNB treasury, marking a significant step in corporate adoption of cryptocurrency for strategic financial management.
Windtree Therapeutics, a Nasdaq-listed biotech company, is launching a $200M BNB crypto treasury strategy, marking a significant move in institutional crypto adoption.